Evaluation of a New Communication Aid Tool to Favor Global Patient Centered Care

Recruiting now · Not applicable

Conditions studied: Parkinson's Disease

In brief

PARKINSUN is a new communication aid tool, expected to favor global patient centered care for PD patients during consultation with GPs and neurologists. Two groups of patients will be randomized to use or not PARKINSUN when they consult their physicians every 3 months during 7 months.

Key facts

Study ID

NCT04179695

Run by

University Hospital, Lille

People needed

120

Starts

2020-07-21

Expected to finish

2026-12-01

Last updated by the study team

2025-12-23

Who can join

Age: 18 and older, up to 90. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Adult men and women with all stages of PD
• Without severe chronic neurological or mental or psychiatric pathology
• Absence of cognitive impairment affecting autonomy (MDS criteria of dementia and MOCA > 22)
• able to come (alone or accompanied) to consultation
• Affiliate or beneficiary of a social security scheme
• Subject having signed informed consent
• Patient willing to comply with all procedures of the study and its duration

You may not qualify if…

• Administrative reasons: impossibility of receiving informed information, inability to participate in the whole study, absence of coverage by the social security system, refusal to sign consent.
• Subject under tutelage or curtailer.
• Subject not fluent in the French language to understand the instructions necessary to carry out the cognitive tests.

Where it is running

• Hopital Roger Salengro, CHU Lille — Lille, France (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.